Editing
Phage Display
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Reagents == M13K07 from == M13K07 helper phage amplification == Infect 200 mg/mL XLI-Blue or TG1 at an OD600 of 0.4 with 10 mL of 100-fold serial dilutions of M13KO7 helper phage in a 37 ℃ water bath for 30 min. Add to 3 mL molten top agar (50 ℃) and pour onto warm LB plates. Allow to set and incubate overnight at 37 ℃. <br/>Pick a small plaque into 5 mL of fresh SB at an OD600 of 0.4. Grow for about 2hr shaking at 37 ℃. <br/>Add to 500 mL SB in a 2 litre flask and grow shaking at 37 ℃ for 1hr. Add kanamycin to a final concentration of 50 mg/mL. Grow overnight shaking at 37 ℃. <br/>Spin overnight culture at 10,800 g for 15 min. Add 100 mL 5 X PEG/NaCl to 400 mL supernatant and leave for 1 hr on ice. <br/>Spin 10,800 g for 30 min. Pour away PEG/NaCl. Re-suspend the pellet in 8 mL PBS and spin at 11,600 g for 10 min to remove any remaining bacterial debris (the titer of helper phage should be in the range of 1012-1013 pfu/mL). '''Preparation of bacterial cells''' 1. Pick a single colony from a freshly streaked plate with the phagemid-containing bacteria and inoculate a 3-ml culture of 2xYT medium supplemented with ampicillin 100 µg/ml and glucose 1% w/v. In absence of IPTG and presence of glucose 1% w/v, the expression of the g3p fusion protein is repressed; this helps preventing loss of phagemid or selection of insertless clones, and improves library integrity. 2. Incubate o/n at 37ºC with agitation at 250 rpm. 3. In the morning, dilute an aliquot of the culture 1:20 v/v with fresh 2xYT medium in a new culture tube and incubate for one hour at 37ºC with agitation at 250 rpm. It is important to dilute the glucose to 0.1% or less to prevent the catabolite repression of the lac operator. 4. Take a small aliquot in sterile conditions and measure the absorbance at 600 nm of a 1:10 dilution in 2xYT medium (A600). With SS320 or TG1 strains, absorbance should be close to 0.5 OD and cells are ready to be transduced. If necessary adjust the length of the incubation to your conditions '''Helper phage transduction ''' It is recommended that incubate directly at 37ºC with agitation at 250 rpm for 30 min to one hour after adding the helper phage. The number of transductants increases over time, especially during the last 30 min of incubation. The total number of transductants is not increased by either pre-incubating bacteria without agitation for 10 min prior to adding the helper phage (sometimes said to regenerate pili destroyed by strong agitation) or after adding the phage (sometimes said to promote transduction). In fact we have noted that in our conditions a lack of agitation during the transduction period results in smaller number of transductants and variable virion production. Add helper phage when the bacterial culture reaches an optical density at 600 nm between 0.4 OD and 0.5 OD; large amounts of nonsuperinfected cells may decrease virion production above 0.5 OD while disparities caused by differences in phage growth rates will be amplified at lower ODs. 1. For product PH010L (concentrated M13KO7), add 1 µl of M13KO7 phage per 1 ml of bacterial culture with A600 at 0.5 OD. This corresponds to a multiplicity of infection (MOI) around 18 and a number of pfu roughly 3 times the number of bacteria in the culture medium. For product PH010S, use 9 μl of M13KO7 phage per 1 ml of bacterial culture with A600 at 0.5 OD. This corresponds to a MOI around 9 and a number of pfu equivalent to 1.5 time number of bacteria in the culture medium. 2. Incubate for 1 h at 37°C and 250 rpm. 3. Add ampicillin 100 µg/ml, kanamycin 50 µg/ml, and IPTG 200 µM; lower the temperature to 30ºC and incubate 8 h to overnight before proceeding to phage purification. The amount of IPTG to add depends on the phagemid, e.g. phagemids such as pADL-23c, pHEN2 or pComb3 do not require IPTG while pADL-10b does require IPTG == Primer Design == Mouse Primers === '''3' LC primer''' Ck1 CATGTCTAGAACACTCATTCCTGTTGAAGCTCTTG<br/><br/>'''5' LC primers''' VkA CATGGAGCTCGATGTTTTGATGACCCAAACTCCA<br/>VkB GATCGAGCTCGACATTGTGCTCACCCAATCTCC<br/>VkC CATGGAGCTCGACATTGTGCTRACCCAGTCTTCCA<br/>VkD CATGGAGCTCGACATCCAGATGACNCAGTCTCAA<br/>VkE CATGGAGCTCCAAATTGTTCTCACCCAGTCTCCA<br/>VkF CATGGAGCTCGAAAATGTGCTTCACCCAGTCTCCA '''3' HC primers''' Ig<font color="#545454" face="Roboto, arial, sans-serif" size="2">G</font>1 AGGCTTACTAGTTATGCAAGGCTTACAACC<br/>Ig<font color="#545454" face="Roboto, arial, sans-serif" size="2">G</font>2A AGGCTTACTAGTACAGGGCTTGATTGTGGGCCC<br/>Ig<font color="#545454" face="Roboto, arial, sans-serif" size="2">G</font>2B AGGCTTACTAGTACAGGGGTTCAGTGTTGAAATGG '''5' HC primers''' IA TGGAGGCTTCTCGAGGAKGTGCAGCTTCAGGAGTC<br/>IB TGGAGGCTTCTCGAGCAGGTGCAGCTGAAGSAGTC<br/>IIA TGGAGGCTTCTCGAGSAGGTCCAGCTGCARCAGTC<br/>IIB TGGAGGCTTCTCGAGCAGGTCCARCTGCAGCAGYTTGG<br/>IIC TGG AGGCTTCTCGAGGAGGTTCAGCTGCAGCAGTC<br/>IIIA TGGAGGCTTCTCGAGGARGTGAAGCTGGTGGARTCTGG<br/>IIIB TGGAGGCTTCTCGAGGAGGTGAAGCTTCTGGAGTCTGG<br/>IIIC TGGAGGCTTCTCGAGGAAGTGAAGCTTGAGGAGWCTGG<br/>IIIDA TGGAGGCTTCTCGAGGAAGTGCAGCTGGTGGAGTCTGG<br/>IIIDB TGGAGGCTTCTCGAGGAAGTGATGCTGGTGGAGTCTGG<br/>VA TGGAGGCTTCTCGAGGAGGTYCAGCTKCAGCAG<br/>CH1 GCCAAAACGACACCCCCA === Human Primers === '''3' LC kappa primer''' Ck Ck1z GCGCCGTCTAGAATTAACACTCTCCCCTGTTGAAGCT<br/>CTTTGTGACGGGCGAACTCAG '''5' LCkappa primers''' 1 Vk1a GACATCGAGCTCACCCAGTCTCCA<br/> 2 Vk2a GATATTGAGCTCACTCAGTCTCCA<br/>3 Vk3a GAAATTGAGCTCACGCAGTCTCCA kappa Constant CONk ACTGTGGCTGCACCATCTG '''3' LC lambda primer''' Clambda Cl2 CGCCGTCTAGAACTATGAACATTCAGG<br/><br/>'''5' LC lambda primers''' 1,2 Vl1,2 CAGTCTGAGCTCACTCAGCCRCCC<br/> 3 Vl3 CAGCCTGAGCTCACTCAG<br/>4,5,9 Vl4,5,9 TCTGTGGAGCTCCAGCCGCCCTCAGTG<br/>6 Vl6 AATTTTGAGCTCACTCAGCCC<br/>7 Vl7 CAGGCTGAGCTCACTCAGGAG<br/>8 Vl8 CAGACTGAGCTCACCCAGGAG<br/>10 Vl10 CAGGCAGAGCTCACTCAGCCA<br/>lambda Constant CONl2 AAGGCTGCCCCCACGGTCACTCTG '''Human HC Primers''' '''3' HC primers''' g: gamma Cg1z g1 GCATGTACTAGTTTTGTCACAAGATTTGGG<br/> Cg2z g2 CGGTGGACTAGTGACACAACATTTGCG<br/>Cg3z g3 TGGGCAACTAGTGCATGTGTGAGTTGTG<br/>Cg4z g4 TGGGCAACTAGTGCATGGGGGACCATATTTGGA<br/>CONga g1,2,3,4 TCCACCAAGGGCCCATCG '''5' HC primers''' VH1a 1 and 4 CAGGTGCAGCTCGAGCAGTCTGGG<br/> VH1f 1 and 4 CAGGTGCAGCTGCTCGAGTCTGG<br/>VH2fN 2 CAGATCACCCTCGAGGAGTCTGGT<br/>VH3a 3 GAGGTGCAGCTCGAGGAGTCTGGG<br/>VH3f 3 GAGGTGCAGCTGCTCGAGTCTGGG<br/>VH5f 5 GAGGTGCAGCTCGAGCAGTCTGGA<br/>VH6f 6 CAGGTACAGCTGCTCGAGTCAGGTCCA [[Category:Antibodies]] === AY Protocol === p19BsrG1<br/>AGCTGTCATGTACACTCCCAAGTTCAACTTCAGCAGTCTGGCGC<br/>pPaniBsrG1<br/>AGCTGTCATGTACACTCCCAAGTTCAACTGCAAGAGTCTGGCCCT<br/>pHer2BsrG1<br/>AGCTGTCATGTACACTCCGAAGTTCAACTTGTGGAATCTGGCGGC<br/>pCMVFor<br/>CGCAAATGGGCGGTAGGcGTG<br/>pCMVrev<br/>CAACATAGTTAAGAATACCAGTC<br/>VHH1SfiFor<br/>CATGCCATGACTCGCGGCCCAGCCGGCCATGGCCCAGGTGCAGCTGGTGCAGTCTGG<br/>VHH2SfiFor<br/>CATGCCATGACTCGCGGCCCAGCCGGCCATGGCCCAGGTCACCTTGAAGGAGTCTGG<br/>VHH3SfiFor<br/>CATGCCATGACTCGCGGCCCAGCCGGCCATGGCCCAGGTGCAGCTGGTGGAGTCTGG<br/>VHH4SfiFor<br/>CATGCCATGACTCGCGGCCCAGCCGGCCATGGCCCAGGTGCAGCTGCAGGAGTCGGG<br/>pPaniBsrG1<br/>AGCTGTCATGTACACTCCCAAGTTCAACTGCAAGAGTCTGGCCCTG<br/>p19BsrG1<br/>AGCTGTCATGTACACTCCCAAGTTCAACTTCAGCAGTCTGGCGC<br/>pHer2BsrG1<br/>AGCTGTCATGTACACTCCGAAGTTCAACTTGTGGAATCTGGCGGC<br/>HCkRev <br/>AGACTCTCCCCTGTTGAAGCTCTT<br/>pADLFor<br/>TTTACACTTTATGCTTCCGGCTCGTATGTTG<br/>pADLRev<br/>AGGTTTTGCTAAACAACTTTCAAC<br/>pG2CdBssHII<br/>GCCAGGCTCAAGGCCCGCATGCCCGACGGCGA<br/>HuIgMRev<br/>TGGAAGAGGCACGTTCTTTTCTTT<br/>C_Rev<br/>AGACTCTCCCCTGTTGAAGCTAAG<br/>C_Rev<br/>TGAAGATTCTGTAGGGGCCACTGTCTT<br/>HuJH12Rev<br/>GGAAGATCTAGAGGAACCACCTGAGGAGACGGTGACCAGGGTGCC<br/>HuJH3Rev<br/>GGAAGATCTAGAGGAACCACCTGAAGAGACGGTGACCATTGTCCC<br/>HuJH45Rev<br/>GGAAGATCTAGAGGAACCACCTGAGGAGACGGTGACCAGGGTTCC<br/>HuJH6Rev<br/>GGAAGATCTAGAGGAACCACCTGAGGAGACGGTGACCGTGGTCCC<br/>pCHIBack<br/>GCTCGGGGAAGTAGTCCTTCACCAGG<br/>pCKBACK<br/>TTCCAGATTTCAACTGCTCATCAG<br/>HuVH1B7AFor<br/>TACTCGCGGCCCAGCCGGCCATGGCTCAGRTGCAGCTGGTGCARTCTGG<br/>HuVH1CFor<br/>TACTCGCGGCCCAGCCGGCCATGGCTSAGGTCCAGCTGGTRCAGTCTGG<br/>HuVH2BFor<br/>TACTCGCGGCCCAGCCGGCCATGGCTCAGRTCACCTTGAAGGAGTCTGG<br/>HuVH3BFor<br/>TACTCGCGGCCCAGCCGGCCATGGCTSAGGTGCAGCTGGTGGAGTCTGG<br/>HuVH3CFor<br/>TACTCGCGGCCCAGCCGGCCATGGCTGAGGTGCAGCTGGTGGAGWCYGG<br/>HuVH4BFor<br/>TACTCGCGGCCCAGCCGGCCATGGCTCAGGTGCAGCTACAGCAGTGGGG<br/>HuVH4CFor<br/>TACTCGCGGCCCAGCCGGCCATGGCTCAGSTGCAGCTGCAGGAGTCSGG<br/>HuVH5BFor<br/>TACTCGCGGCCCAGCCGGCCATGGCTGARGTGCAGCTGGTGCAGTCTGG<br/>HuVH6AFor<br/>TACTCGCGGCCCAGCCGGCCATGGCTCAGGTACAGCTGCAGCAGTCAGG<br/>HuV_5For<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGGAAACGACACTCACGCAGTCTCC<br/>HuV_6For<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGGAAATTGTGCTGACTCAGTCTCC<br/>HuV_1AFor<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGCAGTCTGTGCTGACTCAGCCACC<br/>HuV_1BFor<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGCAGTCTGTGYTGACGCAGCCGCC<br/> <br/>HuV_2For<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGCARTCTGCCCTGACTCAGCCT<br/>HuV_3AFor<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGTCCTATGWGCTGACTCAGCCACC<br/>HuV_3BFor<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGTCTTCTGAGCTGACTCAGGACCC<br/>HuV_4For<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGCACGTTATACTGACTCAACCGCC<br/>HuV_5For<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGCAGGCTGTGCTGACTCAGCCGTC<br/>HuV_6For<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGAATTTTATGCTGACTCAGCCCCA<br/>HuV_78For<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGCAGRCTGTGGTGACYCAGGAGCC HuV_9For<br/>GGTGGCGGTGGCTCGGGCGGTGGTGGGCWGCCTGTGCTGACTCAGCCMCC<br/>LinkerFor, verified<br/>GGTGGTTCCTCTAGATCTTCCTCCTCTGGTGGCGGTGGCTCGGGCGGTGGTGGG HuJ_1RevSfiI, verified<br/>TGGTGTTGGCCTCCCGGGCCACTAGTACGTTTGATHTCCASYTTGGTCCC<br/>HuJ_1_2RevSfiI, verified<br/>TGGTGTTGGCCTCCCGGGCCACTAGTACCTAGGACGGTGACCTTGGTCCC HuJ_2RevSfiI, verified<br/>TGGTGTTGGCCTCCCGGGCCACTAGTACGTTTAATCTCCAGTCGTGTCCC HuJ_2_2RevSfiI, verified<br/>TGGTGTTGGCCTCCCGGGCCACTAGTACCTAGGACGGTCAGCTTGGTCCC HuJ_3RevSfiI, verified<br/>TGGTGTTGGCCTCCCGGGCCACTAGTACYTAAAACGGTGAGCTGGGTCCC
Summary:
Please note that all contributions to ELN may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
ELN:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Category:
Main page
To Do
Tasks
My ELN
Weekly Reports
Buffer Recipe
SOP
Protocols
Inventories
Projects
Products
Customers
Contacts
Suppliers
Vectors
Vector Map
Clones
Cloning
Sequencing
NGS
Protein Expression
Purchaseing
QC
293 Expression
CHO Expression
Sf9 Expression
Protein Purification
Stem Cells
Cytokines
Protein Kinases
GPCR
Cell Lines
Competent Cells
Viral Proteins
VLP
Baculovirus
AAV
Adenovirus
Lentivirus
Virus Titering
Antibodies
Transfection
ELISA
qPCR RT-PCR
ImmunoAssay
Multiplex BioAssa
Lateral_Flow
Conjugation
Compounds Synthesis
BioEngineering
GenomeEngineering
Services
Software
Ideas
Links
Knowledgebase
Employees
Company
Tools
What links here
Related changes
Page information
Navigation
Special pages